The Global Soft Tissue Repair Market will be valued at 6,943.4 Million US$ in 2023 and is anticipated to exhibit a CAGR of 5.93% during the forecast period (2023-2030). Increasing product launches by major market players is expected to drive market growth over the forecast period.Moreover, aging population and increasing obesity rate are expected to boost the market growth during the forecast period. For example, in June 2022, according to the U.S. Food and Drug Administration (FDA) more than 1 million hernia treatments are performed each year in the U.S. Similar trends are observed in other developing and industrialized countries like USA, Canada, Japan, etc. Therefore, aging population and increasing obesity are expected to drive the global soft tissue repair market over the forecast period.
Analysts’ Views on Global Soft Tissue Repair Market:
Global soft tissue repair market growth can be driven by increased incidence of sports related injuries, orthopedic trauma, breast reconstruction and hernia. For instance, according to a report published by National Centre for Biotechnology Information (NCBI), in May 2021, the 10 most common sports practiced by the study participants were respectively: swimming, weight training, athletics, soccer, basketball, tennis, judo, paddle tennis, volleyball, and cycling. Out of these 10 sports, soccer, judo, and basketball have the highest injury rate, and weight training, cycling, and swimming have the lowest injury rate. The total number of injuries was 529. Hence, increasing incidence of sport related injuries is expected to drive the global market in the forecast period.
Figure 1. Global Soft Tissue Repair Market Share (%), By Product Type, 2023
Global Soft Tissue Repair Market- Driver
Increasing aging population and obesity
Increasing prevalence of obesity is expected to boost growth of the global soft tissue repair market over the forecast period. For instance, according to a report published by World Heath Organization (WHO), in June 2021, Worldwide obesity has almost tripled since 1975. Also, The World Obesity Atlas 2022, published by the World Obesity Federation, predicted that thousand million people globally, including 1 out of 5 women and 1 out of 7 men, will be living with obesity by 2030.
Moreover, rising geriatric population is also expected to support the growth of the global soft tissue repair market. For instance, in May 2022, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.
Increasing sport-related injuries
Increasing sports injuries such as ankle sprain, hip muscle strain Injuries, tendonitis, bursitis, stress injuries due to increased interest of sports in youths. For instance, in September 2022, according to report published by National Centre for Biotechnology Information, in recent years, prevalence of achilles tendinopathy has increased, due to the increase in the number of people participating in sports. A large prospective cohort study founded that the cumulative lifetime incidence of achilles tendinopathy in male runners was more than 50%. Hence, increased participation in sports leads to increase in sports-related injuries, which significantly drives the growth of the overall market.
|Base Year:||2022||Market Size in 2023:||US$ 6,943.4 Mn|
|Historical Data for:||2017 to 2021||Forecast Period:||2023 to 2030|
|Forecast Period 2023 to 2030 CAGR:||5.93%||2023 Value Projection:||US$ 10,392.1 Mn|
B. Braun Melsungen AG, Baxter, BD, Johnson & Johnson Private Limited, Stryker Corp., Integra LifeSciences Corporation, Medtronic plc, Acera Surgical, Inc., Anthrex, Inc., Acelity L.P. Inc., Biorez, Aroa Biosurgery Limited, Misonix, Inc., Ortho Regenerative Technologies Inc., AlloSource, Boston Scientific Corporation, TEIJIN LIMITED, and Smith+Nephew, CONMED Corporation.
|Restraints & Challenges:||
Rise in cosmetic surgeries
Reconstructive plastic surgery, soft tissue repair items such as tissues and grafts, and suture anchors plays an important role in the development and progress of global soft tissue repair market. In 2020, The American College of Plastic Surgeons successfully released its annual plastic surgery statistics, showing that 1.8 million cosmetic surgeries and 15.9 million minimally invasive cosmetic surgeries were performed in the U.S. in 2020, reporting 1% increase. At the same time, 5.8 million reconstructive surgeries were performed in theU.S Hence, increasing demand for cosmetic surgery is driving the overall market.
Improved reimbursement scenario
The improved reimbursement scenario is expected to drive the market over the forecast period. For instance, according to Arthrex, Inc., a global medical device company and leader in new product development and medical education, in 2023, stated that US$ 653.61 million will be awarded to the injuries of leg (tibia and fibula) and ankle.
Figure 2. Global Soft Tissue Repair Market Share (%), by Region, 2023
Global Soft Tissue Repair Market- Regional Analysis
Among region, North America is expected to dominate the global market over the forecast period, due to increasing acquisition of companies by the key market players in this region. For instance, in July 2021, BD, a medical technology company, acquired Tepha, Inc., a medical device manufacturing company, to drive new innovations in soft tissue repair and regeneration.
The market in the Asia-Pacific is expected to showcase the fastest growth rate with respect to economy, globally, in the coming years. Several emerging economies, such as India, China, Malaysia, Vietnam, etc., are present in this region. Owing to increasing healthcare expenditure by the government organizations in this region, there is an increase in the development of healthcare infrastructure, which is expected to drive the market growth in the forecast period. For instance, in 2020, according to a report published by Macrotrends LLC, a research platform that enables users to screen and research stocks, there was 4.35% increase in healthcare expenditure in the Asia Pacific region.
Global Soft Tissue Repair Market– Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic and lockdowns in various countries, across the globe, have impacted the financial status of businesses across all sectors, including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdowns in several regions. Private healthcare is one such sector that has been impacted significantly by the COVID-19 pandemic.
Furthermore, healthcare providers were facing challenges in terms of additional manpower, equipment, consumables, and other resources, which were required to ensure safety in hospitals and to provide treatment to patients with other diseases. This has impacted the overall healthcare market negatively.
During the COVID-19 pandemic, global soft tissue repair market was negatively impacted due to the augmented demand for treatment options for soft tissue injuries and decrease in the supply of drugs and treatment options to treat these injuries, due to restrictions imposed by the government during COVID-19.
For instance, according to an article published by PubMed Central, in July 2020, a survey was conducted and it was found that the all hospitals had to sort the urgency of their daily surgical procedures and had to consider non-surgical methods wherever possible.
Global Soft Tissue Repair Market Segmentation:
The global soft tissue repair market report is segmented into product type, application end user and region.
Based on Product Type, the market is segmented into synthetic, allograft, xenograft, and alloplast. Out of which, the allograft segment is expected to dominate the global soft tissue repair market during the forecast period due to increasing product launches by key market players.
Based on Application, the market is segmented into breast reconstruction, hernia, dermatology, orthopedics, dental, vaginal sling, and others. Out of which, the hernia segment is expected to dominate the market over the forecast period due to increasing number of hernia cases in the developed and developing coutries like China, India, Japan, etc.
By End User, the market is segmented into hospitals, ambulatory surgical centers, and clinics. Out of which, the hospitals segment is expected to dominate the market over the forecast period due to increasing incidence of sport related injuries.
Among all segmentation, the application segment has the highest potential due increasing cases of hernia and breast reconstruction. For instance, the National Centre For Biotechnology Information (NCBI) published an article, in 2019, which stated that the lifetime prevelance of inguinal hernias is estimated to be 27-43% in males and 3-6% in females. Also, more than 20 million hernia treatments are performed every year across the globe.
Global Soft Tissue Repair Market Cross Sectional Analysis:
In the product type segment, allograft segment held a dominant position in the North America region, due to the increasing number of product launches by key market players. For instance, in August 2021, AlloSource, one of the largest human tissue provider company, launched AlloMend Ultra-Thick Acellular Dermal Matrix (ADM) in the AlloMend Product Line to support demanding Soft Tissue Applications.
Global Soft Tissue Repair Market: Key Developments
On January 5, 2023, Zimmer Biomet Holdings, Inc., a medical technology company, entered into an agreement to acquire Embody, Inc., a medical device company focused on soft tissue healing. This acquisition will advance the active portfolio management strategy and align with the focus on acquiring tech and products in fast-growing sub-markets that will be accretive to overall growth of the global soft tissue repair market.
In February 2022, Johnson & Johnson Private Limited, a medical device company, acquired CrossRoads Extremity Systems, a Tennessee-based foot and ankle company that provides a broad range of procedure-specific, sterile-packed implants and instrumentation systems cleared for lower extremity indications.
In December 2022, Stryker, a medical device and equipment manufacturing company, announced the launch of Citrefix, a suture anchor system that uses the company’s Citregen material designed to mimic the chemistry and structure of native bone to support bone regeneration and natural healing.
In August 2022, CONMED Corporation, a orthopedic products manufacturing company, announced a definitive agreement to acquire privately held Biorez, Inc., a medicine company focused on the development of tendon and ligament healing to advance the healing of soft tissue using its proprietary BioBrace Implant technology.
The increasing adoption of organic growth strategies like product launch and inorganic strategies like company acquisition is expected to drive the global soft tissue market in the forecast period by increasing the opportunities for new players in the market.
Global Soft Tissue Repair Market: Restraint
Side effect associated with improper wound care in soft tissue surgeries
The major factor that can affect the growth of the global soft tissue repair market over the forecast period includes side effects associated with improper wound care after soft tissues surgery. The side effects of improper wound care can be serious and life-threatening. For instance, according to an article published, in April 2021, it was found that in order to heal the wound properly, an antibiotic ointment should be spread over wound to keep the it soft and moist, before covering it with a bandage. If the skin is too dry, the wound may form a scab, which can lead to scarring.
Global Soft Tissue Repair Market: Key Players
Major players operating in the global soft tissue repair market include B. Braun Melsungen AG, Baxter, BD, Johnson & Johnson Private Limited, Stryker Corp., Integra LifeSciences Corporation, Medtronic plc, Acera Surgical, Inc., Anthrex, Inc., Acelity L.P. Inc., Biorez, Aroa Biosurgery Limited, Misonix, Inc., and Ortho Regenerative Technologies Inc., AlloSource, Boston Scientific Corporation, TEIJIN LIMITED, Smith+Nephew, CONMED Corporation.
Soft tissue repair or healing is often referred to the sequential process by which damaged tissue is replaced with a living tissue and is further divided into three main categories: tissue repair, regeneration, and reconstruction. Soft tissue surgery is primarily aimed at improving joint stability by restoring the underlying length of muscles, tendons, and ligaments. Common soft tissue surgeries include tendon grafting, fasciotomy, cartilage resection or repair, muscle repair, and ligament reconstruction. Rising emergency surgeries to treat sports injuries, increasing product approvals, and expansion of medical infrastructure in developing countries are expected to drive market growth during the forecast period. For instance, in December 2022, an article published by Centers for Disease Control and Prevention (CDC) stated that around 18.6 million people in U.S. were admitted to hospitals for emergency surgeries
Increasing impact of sport and physical activity on health is now recognized around the world. Rising sports injuries such as ankle sprains, tendonitis, hip muscle injuries, bursitis, and stress-induced injuries due to youth interest in sports, will boost the growth of the market during the forecast period. Moreover, increased adoption of organic growth strategies such as product launches by key market players to expand their product portfolios and that will drive market growth during the forecast period. For example, in May 2022, Paragon 28,a leading medical device company, announced the launch of a new product named TenoTac 2.0. TenoTac 2.0 is a soft tissue stabilization system that can be used for hammer toe and soft tissue repair.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.View All Our Clients